CALC Earnings — CalciMedica, Inc. Common Stock Post-ER Performance | BigEarnings
CALC — CalciMedica, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$0.82
Market Cap$13.0M
P/E—
52W Range$0.46 – $7.20
Next Earnings2026-08-11
About CalciMedica, Inc. Common Stock
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
